Keywords: Spectroscopy, Prostate, MetabolomicsCurrently, Prostate Cancer (PC) diagnosis is achieved either through invasive measures, like biopsies, or imaging techniques, such as sonography, CT, and MRI. The biomarker PSA in blood is used for screening, however its use is considered controversial. It doesn’t show to reduce PC all-cause mortality and PSA screening comes with a high number of false-positive results and associated risks. Here, using HRMAS MRS, we studied human urine samples obtained from prostate cancer patients and healthy controls to reveal potential PC-associated metabolomic changes, which may assist with early and non-invasive PC diagnosis and screening.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords